Dubai, UAE, 22nd April 2020: Supporting the efforts of the medical community in the face of the global pandemic, Globalpharma, a wholly-owned subsidiary of Dubai Investments PJSC, has confirmed readiness for manufacturing & supplying essential medicines & medical requirements needed to face the disease and its consequences in the coming period.
Globalpharma has confirmed availability of the medicines aimed at supporting the fight against the global pandemic.
Globalpharma has confirmed studying and accordingly preparing the World Health Organization (WHO) latest recommended formulas in the manufacturing of the sanitizers. In parallel to scaling up operations to produce larger quantities, the Company is working closely with local manufacturers and suppliers specialized in sanitizer production, implementing a speedy manufacturing formulation process at a larger scale, ensuring timely availability of the sanitizers locally. Local tests are being initiated to ensure optimum performance and safety.
The company is studying the possibilities of manufacturing and supplying other medical requirements that will help the efforts to curb the spread of COVD-19.
“As a responsible pharmaceutical company, we want to support the government and the community with the best means of treatment and support. We have collaborated all our resources and are partnering with specialized manufacturers to ensure a seamless production chain and provide timely medical support”, said Mohammed Saeed Al Raqbani, General Manager, Dubai Investments Industries.
Globalpharma manufactures and commercializes pharmaceutical products under CGMP (current good manufacturing practice) conditions including antibiotics, cardiovascular, anti-ulcerants, analgesic, NSAIDs (Nonsteroidal anti-inflammatory medicines), food supplements, vitamins, anti-diabetics, respiratory products and anti-histamine formulations
“At Globalpharma we are well known for following the highest quality of good manufacturing practice (GMP) standards. We are keen on implementing the same to the manufacturing process of the urgently needed high quality sanitizers and similar products”, said Basem Al Barahmeh, General Manager, Globalpharma Co. L.L.C
Globalpharma is a leading pharmaceutical company in the UAE which was established in 1998 and started operations in 2003. It is a wholly owned subsidiary of Dubai Investments. The Globalpharma manufacturing facility in Dubai Investments Park covers an area of 27.000 square metres and the annual capacity of the plant includes the production of 300 million tablets, 150 million capsules, and over 7 million litres of dry syrup and liquid.